Development and validation of a liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry method for simultaneous analysis of 10 amphetamine-, methamphetamine- and 3,4-methylenedioxymethamphetamine-related (MDMA) analytes in human meconium.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences

• Publication date

  2008-05-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.jchromb.2008.03.029PMID 18424195PMCID PMC2587330
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CENTER FOR DRUG EVALUATION AND RESEARCH

  2009cited by this paper
• Bioanalytical procedures for monitoring in utero drug exposure

  2007cited by this paper
• Drugs of abuse testing in meconium.

  2006cited by this paper
• The Infant Development, Environment, and Lifestyle Study: Effects of Prenatal Methamphetamine Exposure, Polydrug Exposure, and Poverty on Intrauterine Growth

  2006cited by this paper
• Assessment of exposure to opiates and cocaine during pregnancy in a Mediterranean city: preliminary results of the "Meconium Project".

  2005cited by this paper
• Determination of methadone, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine, 2-ethyl-5-methyl-3,3-diphenylpyraline and methadol in meconium by liquid chromatography atmospheric pressure chemical ionization tandem mass spectrometry.

  2005cited by this paper
• Application of a validated high-performance liquid chromatography-mass spectrometry assay to the analysis of m- and p-hydroxybenzoylecgonine in meconium.

  2005cited by this paper
• Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition.

  2004cited by this paper
• Development and validation of a high-performance liquid chromatography-mass spectrometry assay for determination of amphetamine, methamphetamine, and methylenedioxy derivatives in meconium.

  2004cited by this paper
• Clarke's analysis of drugs and poisons in pharmaceuticals, body fluids and postmortem material

  2004cited by this paper
• New designer drug p-methoxymethamphetamine: studies on its metabolism and toxicological detection in urine using gas chromatography-mass spectrometry.

  2003cited by this paper
• LC-MS/MS analysis of pholedrine in a fatal intoxication case.

  2003cited by this paper
• Prevalence of fatty acid ethyl esters in meconium specimens.

  2003cited by this paper
• Effects of Prenatal Methamphetamine Exposure on Fetal Growth and Drug Withdrawal Symptoms in Infants Born at Term

  2003cited by this paper
• Development and validation of a liquid chromatography-mass spectrometry assay for the determination of opiates and cocaine in meconium.

  2003cited by this paper
• Validation of a new biomarker of fetal exposure to alcohol.

  2003cited by this paper
• Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS.

  2003cited by this paper
• Toxicokinetics of Amphetamines: Metabolism and Toxicokinetic Data of Designer Drugs, Amphetamine, Methamphetamine, and Their N-Alkyl Derivatives

  2002cited by this paper
• Drug abuse's smallest victims: in utero drug exposure.

  2002cited by this paper
• GC-MS determination of heroin metabolites in meconium: evaluation of four solid-phase extraction cartridges.

  2001cited by this paper
• The Maternal Lifestyle Study: drug use by meconium toxicology and maternal self-report.

  2001cited by this paper
• Analysis of nonsteroidal antiinflammatory drugs in meconium and its relation to persistent pulmonary hypertension of the newborn.

  2001cited by this paper
• An LC-MS-MS method for the comprehensive analysis of cocaine and cocaine metabolites in meconium.

  2000cited by this paper
• Identification and analysis of the major metabolites of cocaine in meconium.

  1999cited by this paper
• Immunoassay and GC-MS procedures for the analysis of drugs of abuse in meconium.

  1999cited by this paper
• Determination of drugs of abuse in meconium.

  1998cited by this paper
• Quantitation of N-ethyl-3,4-methylenedioxyamphetamine and its major metabolites in human plasma by high-performance liquid chromatography and fluorescence detection.

  1998cited by this paper
• Analysis of methadone and its primary metabolite in meconium.

  1997cited by this paper
• Cocaine disposition in meconium from newborns of cocaine-abusing mothers and urine of adult drug users.

  1996cited by this paper
• Toxicological detection of the designer drug 3,4-methylenedioxyethylamphetamine (MDE, "Eve") and its metabolites in urine by gas chromatography-mass spectrometry and fluorescence polarization immunoassay.

  1996cited by this paper
• False-positive and false-negative rates in meconium drug testing.

  1995cited by this paper
• Postmortem drug analysis of meconium in early-gestation human fetuses exposed to cocaine: clinical implications.

  1995cited by this paper
• Meconium analysis for cocaine: a validation study and comparison with paired urine analysis.

  1995cited by this paper
• Meconium analysis to assess fetal exposure to nicotine by active and passive maternal smoking.

  1994cited by this paper
• Analysis of morphine and amphetamine in meconium with immunoassay and HPLC-diode-array detection.

  1994cited by this paper
• Detection of cocaine, norcocaine, and cocaethylene in the meconium of premature neonates.

  1994cited by this paper
• A comparison of meconium, maternal urine and neonatal urine for detection of maternal drug use during pregnancy.

  1994cited by this paper
• Postmortem drug analysis of meconium in early-gestation human fetuses exposed to cocaine: Clinical implications

  1994cited by this paper
• Quantitation of benzoylnorecgonine and other cocaine metabolites in meconium by high-performance liquid chromatography.

  1993cited by this paper
• Analysis of meconium for cocaine in neonates.

  1992cited by this paper
• The analysis of cocaine and benzoylecgonine in meconium.

  1992cited by this paper
• Perinatal cocaine and methamphetamine exposure: maternal and neonatal correlates.

  1988cited by this paper
• Methamphetamine Abuse During Pregnancy: Outcome and Fetal Effects

  1988cited by this paper
• Perinatal cocaine and methamphetamine exposure: Maternal and neonatal correlates

  1987cited by this paper
• AMPHETAMINE ADDICTION AND PREGNANCY

  1981cited by this paper
• Metabolism of ( 14 C)methamphetamine in man, the guinea pig and the rat.

  1972cited by this paper
• Metabolism of [14C]methamphetamine in man, the guinea pig and the rat

  1972cited by this paper

• Fast electromembrane extraction of illicit drugs from meconium

  2026cites this paper
• Determination of Prenatal Substance Exposure Using Meconium and Orbitrap Mass Spectrometry

  2022cites this paper
• Salting out assisted liquid-liquid extraction for liquid chromatography tandem-mass spectrometry determination of amphetamine-like stimulants in meconium.

  2019cites this paper
• Advances in Meconium Analysis for Assessment of Neonatal Drug Exposure

  2019cites this paper
• Meconium analysis as a promising diagnostic tool for monitoring fetal exposure to toxic substances: Recent trends and perspectives

  2018cites this paper
• Detection of Drug-Exposed Newborns

  2018cites this paper
• Bioanalytical methods for determining ecstasy components in biological matrices: A review

  2018cites this paper
• Stability of 21 Cocaine, Opioid and Benzodiazepine Drug Analytes in Spiked Meconium at Three Temperatures.

  2017cites this paper
• Matrix effect management in liquid chromatography mass spectrometry: the internal standard normalized matrix effect.

  2017cites this paper
• Recent advances of liquid chromatography-(tandem) mass spectrometry in clinical and forensic toxicology - An update.

  2016influential citation
• Photocatalytic degradation of methamphetamine by UV/TiO2 - kinetics, intermediates, and products.

  2015cites this paper
• Matrix effect and methods for its elimination in bioanalytical methods using chromatography-mass spectrometry

  2014cites this paper
• Chromatographic behavior of co-eluted plasma compounds and effect on screening of drugs by APCI-LC–MS(/MS): Applications to selected cardiovascular drugs

  2014cites this paper
• MATRIX INFLUENCE ON DETERMINATION OF ORGANOCHLORINE PESTICIDE RESIDUES IN WATER BY SOLID PHASE EXTRACTION COUPLED TO GAS CHROMATOGRAPHY-MASS SPECTROMETRY

  2014cites this paper
• Bioanalysis during pregnancy: recent advances and novel sampling strategies.

  2014cites this paper
• Meconium drug testing reveals maternal misuse of medicinal opioids among addicted mothers.

  2013cites this paper
• Prenatal exposure to substance of abuse: a worldwide problem.

  2013cites this paper
• Chapitre 15 – Amphétamines et dérivés

  2012cites this paper
• LC–MS–MS Method for the Simultaneous Determination of Donepezil Enantiomers in Plasma

  2012cites this paper
• Trends in bioanalytical methods for the determination and quantification of club drugs: 2000-2010.

  2011cites this paper
• Recent advances of liquid chromatography-(tandem) mass spectrometry in clinical and forensic toxicology.

  2011influential citation
• Simultaneous determination of 15 top-prescribed pharmaceuticals and their metabolites in influent wastewater by reversed-phase liquid chromatography coupled to tandem mass spectrometry.

  2011cites this paper
• Development and validation of an HPLC–MS/MS method to quantify clopidogrel acyl glucuronide, clopidogrel acid metabolite, and clopidogrel in plasma samples avoiding analyte back-conversion

  2011cites this paper
• New meconium biomarkers of prenatal methamphetamine exposure increase identification of affected neonates.

  2010cites this paper
• Hydrogen/deuterium exchange on aromatic rings during atmospheric pressure chemical ionization mass spectrometry.

  2010cites this paper
• Analysis of meconium, nails and tears for determination of medicines and drugs of abuse

  2010cites this paper
• Optimization and validation of a hydrophilic interaction liquid chromatography–tandem mass spectrometry method for the determination of 13 top-prescribed pharmaceuticals in influent wastewater

  2010cites this paper
• Preventive doping control screening analysis of prohibited substances in human urine using rapid-resolution liquid chromatography/high-resolution time-of-flight mass spectrometry.

  2010cites this paper
• Broad-spectrum drug screening of meconium by liquid chromatography with tandem mass spectrometry and time-of-flight mass spectrometry

  2010influential citation
• Simultaneous qualitative and quantitative method using liquid chromatography selected reaction monitoring-triggered quantitation-enhanced data-dependent tandem mass spectrometry for the identification and classification of amphetamine-type stimulant abusers in human urine.

  2010cites this paper
• Ethyl glucuronide determination in meconium and hair by hydrophilic interaction liquid chromatography-tandem mass spectrometry.

  2010cites this paper
• A liquid chromatography tandem mass spectrometry method for the simultaneous quantification of 20 drugs of abuse and metabolites in human meconium

  2009cites this paper
• Applications of ultra performance liquid chromatography (UPLC) and tandem mass spectrometry for the detection and quantification of cocaine, amphetamine, and opiate derivatives in human meconium

  2009cites this paper
• Forensic science.

  2009cites this paper
• Validation of bioanalytical LC-MS/MS assays: evaluation of matrix effects.

  2009cites this paper
• Determination of amphetamine and methamphetamine in umbilical cord using liquid chromatography-tandem mass spectrometry.

  2009cites this paper
• Novel Biomarkers of Prenatal Methamphetamine Exposure in Human Meconium

  2009cites this paper
• Simultaneous quantification of nicotine, opioids, cocaine, and metabolites in human fetal postmortem brain by liquid chromatography tandem mass spectrometry

  2009cites this paper
• Simultaneous quantification of buprenorphine, norbuprenorphine, buprenorphine-glucuronide and norbuprenorphine-glucuronide in human umbilical cord by liquid chromatography tandem mass spectrometry.

  2009cites this paper